Stay updated on CIVO Intratumoral Microdosing Clinical Trial

Sign up to get notified when there's something new on the CIVO Intratumoral Microdosing Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIVO Intratumoral Microdosing Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:34:32.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 on the webpage has recently changed to 8, indicating a shift in the number of anti-cancer agents or combinations that can be simultaneously delivered into a patient's tumor tissue using the CIVO device for intratumoral microdose injections in the study protocol.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:22.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed information on eligibility criteria for study participants, including examples and specific inclusion and exclusion criteria. Previously, this section had no information provided.
    Difference
    20%
    Check dated 2024-05-22T21:32:49.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:31:07.000Z thumbnail image

Stay in the know with updates to CIVO Intratumoral Microdosing Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIVO Intratumoral Microdosing Clinical Trial page.